This web site uses cookies. Do you accept the use of external cookies? Yes No Know more x
Survey about achondroplasia
We have designed a questionnaire with the purpose to better know the population connected to achondroplasia.
The questionnaire is optional and anonymous. The data obtained will be used for statistical purposes and to better understand the natural history of achondroplasia. Please consider answering.
If you would like to take the survey later, you can click on the link at the top "Register at BA"
Go to the survey Not now No, thanks

BMN-111 phase 2 results presented at the ASBMR 2015 meeting

2015-10-15Research
Recap on the results from the first 6 months of the phase 2 clinical trial for BMN-111, elicited by a presentation at the American Society for Bone and Mineral Research of 2015.
Read More

Soluble FGFR3 going forward with Therachon

2015-10-01Research
Soluble FGFR3, a drug for achondroplasia under development by TherAchon is moving towards clinical trials. See the summary of their press release here.
Read More

B-701 - New potential treatment for achondroplasia

2015-08-25Research
New potential treatment for achondroplasia being developed by BioClin Therapeutics. It's based on monoclonal antibodies and is also being tested for Urothelial Cell Carcinoma.
Read More

Statins for achondroplasia, at the 12th ISDS meeting - part 1

2015-08-09Research
This is a summary of Dr. Tsumaki's lecture at the 12th ISDS meeting about statins as a potential treatment for achondroplasia.
Read More

BMN-111 Phase 3 ancillary cohort

2015-08-04Research
An excerpt from BioMarin's investor page dated from the 3rd of August 2015, about the results of the Phase 2 clinical study.
Read More

What are the potential treatments for achondroplasia?

2015-07-27Research
A summary of the four drugs under development at the moment for achondroplasia.
Read More
To view this site you need Internet Explorer 8 (or a higher version)
or another internet browser.

Thank You.